A Phase I Study of Erlotinib and Hydroxychloroquine in Advanced Non-Small Cell Lung Cancer

INTRODUCTION: This investigator-initiated study explores the safety, maximum tolerated dose (MTD), clinical response, and pharmacokinetics (PK) of hydroxychloroquine (HCQ) with and without erlotinib in patients with advanced non-small cell lung cancer (NSCLC). METHODS: Patients with prior clinical b...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Goldberg, Sarah B., Supko, Jeffrey G., Neal, Joel W., Muzikansky, Alona, Digumarthy, Subba, Fidias, Panos, Temel, Jennifer S., Heist, Rebecca S., Shaw, Alice T., McCarthy, Patricia O., Lynch, Thomas J., Sharma, Sreenath, Settleman, Jeffrey E., Sequist, Lecia V.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2012
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3791327/
https://ncbi.nlm.nih.gov/pubmed/22878749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e318262de4a
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia